Table 3.

Important clinical and pathological characteristics in endometrial cancer patients according to germline mutation status.

Characteristic	No DM N(%)	LS DM N(%)	Other DM N(%)	p-value No DM vs LS	p-value No DM vs Other
Age at Diagnosis, mean (SD)	62 (10.7)	52 (9.1)	58 (14.7)	p<0.01	p=0.21
Age at Diagnosis <50				p<0.01	p=0.62
Yes	38 (11)	10 (46)	2 (15)
No	308 (89)	12 (55)	11 (85)
BMI				p=0.01	P=0.39
Not Overweight	50 (15)	8 (36)	3 (23)
Overweight	296 (86)	14 (64)	10 (77)
Tumor Location				p<0.01	p=0.98
Corpus	310 (93)	14 (70)	12 (92)
Lower Uterine Segment	25 (8)	6 (30)	1 (8)
MSI or IHC Screen Positive				p<0.01	p=0.91
Yes	31 (9)	19 (91)	1 (8)
No	301 (91)	2 (10)	11 (92)
SGO 5–10% Criteria				p<0.01	p=0.59
Yes	84 (24)	13 (59)	4 (31)
No	262 (76)	9 (41)	9 (69)
Serous Histology				p=0.73	p=0.02
Serous	22 (6)	1 (5)	3 (23)
Other	324 (94)	21 (96)	10 (77)